Literature DB >> 7351747

Opiate withdrawal using clonidine. A safe, effective, and rapid nonopiate treatment.

M S Gold, A C Pottash, D R Sweeney, H D Kleber.   

Abstract

Clonidine hydrochloride was administered to ten patients in an inpatient setting after abrupt discontinuation of chronic methadone hydrochloride administration. Clonidine produced a rapid and statistically significant decrease in opiate withdrawal signs and symptoms. Clonidine administration for 14 days enabled all patients to be successfully detoxified from chronic opiate administration. In all patients studied, clonidine was a safe and effective nonopiate treatment of opiate withdrawal that suppressed the affect, signs, and symptoms of opiate withdrawal. These data support the hypothesis that the alpha 2-adrenergic agonist, clonidine, has substantial antiwithdrawal effect by replacing opiate-mediated inhibition with alpha 2-mediated inhibition of brain noradrenergic activity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7351747

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  30 in total

Review 1.  Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice.

Authors:  Stacey C Sigmon; Adam Bisaga; Edward V Nunes; Patrick G O'Connor; Thomas Kosten; George Woody
Journal:  Am J Drug Alcohol Abuse       Date:  2012-03-12       Impact factor: 3.829

Review 2.  Adverse effects of systemic opioid analgesics.

Authors:  S A Schug; D Zech; S Grond
Journal:  Drug Saf       Date:  1992 May-Jun       Impact factor: 5.606

Review 3.  Substance use modulates stress reactivity: Behavioral and physiological outcomes.

Authors:  Anne Q Fosnocht; Lisa A Briand
Journal:  Physiol Behav       Date:  2016-02-19

Review 4.  Cigarette smoking, nicotine dependence, and treatment.

Authors:  K L Sees
Journal:  West J Med       Date:  1990-05

Review 5.  Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?

Authors:  Timothy E Albertson; James Chenoweth; Jonathan Ford; Kelly Owen; Mark E Sutter
Journal:  J Med Toxicol       Date:  2014-12

6.  Effects of clonidine and morphine on opioid withdrawal in rhesus monkeys.

Authors:  J L Katz
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

7.  Ambiguities of aging: Japanese experience and perceptions of menopause.

Authors:  M Lock
Journal:  Cult Med Psychiatry       Date:  1986-03

Review 8.  Critical care pharmacotherapy. A review.

Authors:  M Tryba; P J Kulka
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

9.  Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.

Authors:  Leslie Amass; Walter Ling; Thomas E Freese; Chris Reiber; Jeffrey J Annon; Allan J Cohen; Dennis McCarty; Malcolm S Reid; Lawrence S Brown; Cynthia Clark; Douglas M Ziedonis; Jonathan Krejci; Susan Stine; Theresa Winhusen; Greg Brigham; Dean Babcock; Joan A Muir; Betty J Buchan; Terry Horton
Journal:  Am J Addict       Date:  2004

10.  Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial.

Authors:  Alexander G Agthe; George R Kim; Kay B Mathias; Craig W Hendrix; Raul Chavez-Valdez; Lauren Jansson; Tamorah R Lewis; Myron Yaster; Estelle B Gauda
Journal:  Pediatrics       Date:  2009-04-27       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.